8-89769900-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003821.6(RIPK2):c.612A>T(p.Ser204Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00194 in 1,607,632 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 32 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 13 hom. )
Consequence
RIPK2
NM_003821.6 synonymous
NM_003821.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.99
Genes affected
RIPK2 (HGNC:10020): (receptor interacting serine/threonine kinase 2) This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-89769900-A-T is Benign according to our data. Variant chr8-89769900-A-T is described in ClinVar as [Benign]. Clinvar id is 707947.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.01 (1521/151958) while in subpopulation AFR AF = 0.0343 (1424/41510). AF 95% confidence interval is 0.0328. There are 32 homozygotes in GnomAd4. There are 677 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1521 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPK2 | NM_003821.6 | c.612A>T | p.Ser204Ser | synonymous_variant | Exon 4 of 11 | ENST00000220751.5 | NP_003812.1 | |
RIPK2 | NM_001375360.1 | c.201A>T | p.Ser67Ser | synonymous_variant | Exon 3 of 10 | NP_001362289.1 | ||
RIPK2 | XM_011517357.3 | c.99A>T | p.Ser33Ser | synonymous_variant | Exon 2 of 9 | XP_011515659.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPK2 | ENST00000220751.5 | c.612A>T | p.Ser204Ser | synonymous_variant | Exon 4 of 11 | 1 | NM_003821.6 | ENSP00000220751.4 | ||
RIPK2 | ENST00000522965.1 | n.*251A>T | non_coding_transcript_exon_variant | Exon 3 of 10 | 1 | ENSP00000429271.1 | ||||
RIPK2 | ENST00000522965.1 | n.*251A>T | 3_prime_UTR_variant | Exon 3 of 10 | 1 | ENSP00000429271.1 |
Frequencies
GnomAD3 genomes AF: 0.0100 AC: 1520AN: 151840Hom.: 32 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1520
AN:
151840
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00260 AC: 642AN: 246756 AF XY: 0.00192 show subpopulations
GnomAD2 exomes
AF:
AC:
642
AN:
246756
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1595AN: 1455674Hom.: 13 Cov.: 31 AF XY: 0.000958 AC XY: 694AN XY: 724156 show subpopulations
GnomAD4 exome
AF:
AC:
1595
AN:
1455674
Hom.:
Cov.:
31
AF XY:
AC XY:
694
AN XY:
724156
Gnomad4 AFR exome
AF:
AC:
1113
AN:
32986
Gnomad4 AMR exome
AF:
AC:
122
AN:
43896
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25966
Gnomad4 EAS exome
AF:
AC:
0
AN:
39272
Gnomad4 SAS exome
AF:
AC:
5
AN:
85500
Gnomad4 FIN exome
AF:
AC:
0
AN:
53336
Gnomad4 NFE exome
AF:
AC:
233
AN:
1108846
Gnomad4 Remaining exome
AF:
AC:
116
AN:
60130
Heterozygous variant carriers
0
71
142
214
285
356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0100 AC: 1521AN: 151958Hom.: 32 Cov.: 32 AF XY: 0.00911 AC XY: 677AN XY: 74306 show subpopulations
GnomAD4 genome
AF:
AC:
1521
AN:
151958
Hom.:
Cov.:
32
AF XY:
AC XY:
677
AN XY:
74306
Gnomad4 AFR
AF:
AC:
0.034305
AN:
0.034305
Gnomad4 AMR
AF:
AC:
0.00499671
AN:
0.00499671
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000147414
AN:
0.000147414
Gnomad4 OTH
AF:
AC:
0.00474383
AN:
0.00474383
Heterozygous variant carriers
0
70
141
211
282
352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 31, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at